Introduction
============

The chemistry of the transition metal complexes of thiosemicarbazones became largely appealing because of their broad profile of pharmacological activity that provides a diverse variety of compounds with different activities [@b1]--[@b4]. Some of the detected biological activities of the thiosemicarbazones and their complexes with transition metal ions are antibacterial, antifungal, antiarthritic, antimalarial, antitumor, antiviral and anti-HIV activities [@b5]--[@b10].

Thiosemicarbazone derivatives containing a 4-acyl-2-pyrazolin-5-one moiety form an important class of organic compounds because of their structural chemistry and biological activities [@b11]. In the field of anticancer research, the pyrazolones exhibited promising antiproliferative activity against human myelogenous leukaemia HL-60 [@b12]. The co-ordinating property of the 4-amino-2,3-dimethyl-1-phenyl-3-pyrazolin-5-one ligand has been modified to give a flexible ligand system, formed by condensation with a variety of reagents such as aldehydes, ketones [@b13]--[@b15], thiosemicarbazides and carbazides, *etc*. [@b16]--[@b18]. The biological properties of thiosemicarbazones are often related and modulated by metal ion coordination.

This work is the result of our systematic studies in this field [@b19]--[@b21]. In this study, we report the synthesis, spectral studies and crystal structures of Cu(II), V(V) and Ni(II) complexes with 1-phenyl-3-methyl-4-benzoyl-5-pyrazolone 4-ethyl-thiosemicarbazone.

Materials and methods
=====================

Antibacterial and antifungal activity
-------------------------------------

The free ligand and metal complexes synthesized were tested for their *in vitro* antibacterial activity against Escherichia coli (O-111), Salmonella abony, Staphylococcus aureus (209-P), Bacillus cereus and their anti-fungal activity against Candida albicans strains using the paper disc diffusion method [@b22] (for qualitative determination) and with serial dilutions in liquid broth [@b23] \[for the determination of minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC)\]. Furaciline and nistatine were used as reference substances.

Qualitative determination of antimicrobial activity was carried out using the disk diffusion method. Suspensions in sterile peptone water from 24 hrs cultures of microorganisms were adjusted to 0.5 McFarland. Mueller-Hinton Petri dishes of 90 mm were inoculated using these suspensions. Paper disks (6 mm in diameter) containing 10 ml of the substance to be tested (at a concentration of 2048 mg/ml in dimethylsulfoxide) were placed in a circular pattern on each inoculated plate. The plates were incubated at 37°C for 24 hrs. The results were read by measuring the diameters of the inhibition zones generated by the tested substances, using a ruler. Determination of MIC (mg/ml) was carried out using serial dilutions in liquid broth method. The materials used were 96-well plates, suspensions of microorganism (0.5 McFarland), Mueller-Hinton broth (Merck, Bucharest, Romania) and solutions of the substances to be tested (2048 mg/ml in dimethylsulfoxide). The following concentrations of the substances to be tested were placed in the 96-well plates: 1024; 512; 256; 128; 64; 32; 16; 8; 4; 2 mg/ml. After incubation at 37°C for 18--24 hrs, the MIC for each tested substance was determined by macroscopic observation of microbial growth, which corresponded well with the lowest concentration of the tested substance where microbial growth was clearly inhibited.

The antimycotic properties were determined in liquid Sabouroud medium (pH 6.8). The inoculates were prepared from fungal stems which were harvested from 3 to 7 day-old cultures. Their concentration in suspension was (2--4)·10^6^ colony forming units per millilitre. Sowings for fungi and micelles were incubated at 37°C during 7 and 14 days, respectively.

Antiproliferative activity
--------------------------

### Cell culture

Human promyelocytic leukaemia cells HL-60 (ATCC, Rockville, MD, USA) were routinely grown in suspension in 90% RPMI-1640 (Sigma-Aldrich, Saint Louis, MO, USA) containing *L*-glutamine (2 nM), antibiotics (100 IU penicillin/ml, 100 μg streptomycin/ml) and supplemented with 10% (v/v) foetal bovine serum, in a 5% CO~2~ humidified atmosphere at 37°C. Cells were currently maintained in continuous exponential growth with dilution of the cells in culture medium twice a week.

### Cell proliferation assay

The cell proliferation assay was performed with 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)2-(4-sulfophenyl)-2H-tetrazolium (MTS) (Cell Titer 96 Aqueous; Promega, Madison, USA USA), which allowed us to measure the number of viable cells. In brief, triplicate cultures of 1 × 10^4^ cells in a total of 100 μl medium in 96-well microtiter plates (Becton Dickinson and Company, Lincoln Park, NJ, USA) were incubated at 37°C, in 5% CO~2~. Compounds were dissolved in DMSO to prepare the stock solution of 1 × 10^−2^ M. These compounds were diluted to the appropriate concentration (1 or 10 μM) with culture media, added to each well and incubated for 3 days. Following each treatment, 20 μl MTS was added to each well and incubated for 4 hrs. MTS is converted to water-soluble coloured formazan by dehydrogenase enzymes present in metabolically active cells. Subsequently, the plates were read at 490 nm using a microplate reader (Molecular Devices, Sunnyvale, CA, USA). The results were reported as the percentage of cell proliferation inhibition compared to the control (basal cell proliferation = 100%).

### Chemistry

The substances 4-ethyl-thiosemicarbazone (Sigma-Aldrich) and 1-phenyl-3-methyl-4-benzoyl-5-pyrazolone (Merck) were used as received. The metal salts CuCl~2~·2H~2~O, CuBr~2~, Cu(OAc)~2~·H~2~O, Cu(NO~3~)~2~·3H~2~O, (VO)SO~4~·2H~2~O, NiCl~2~·6H~2~O (Merck) were used as supplied. Solvents used for the reactions were purified and dried by conventional methods [@b24].

C, H and N analyses were performed with the Carlo-Erba LA-118 microdosimeter and the AAS-1N Carl-Zeiss-Jena spectrometer was used for the determination of Cu(II) and Ni(II). Vanadium was determined following the method described by Fries and Getrost [@b25]. Infrared spectra (4000--400 cm^−1^) were recorded on a Bruker Vertex 70 (Billerica, Mssachusett, USA) spectrophotometer, using KBr pellets. The ^1^H NMR and ^13^C NMR spectra were recorded on a Bruker 400 DRX Billerica, Mssachusett, USA spectrometer in DMSO solution, using TMS as the internal standard. Diffuse reflectance spectra were recorded on a Jasco V-670 (Tokyo, Japan) spectrophotometer, using MgO dilution matrices. Electron paramagnetic resonance (EPR) measurements were performed on polycrystalline powders and DMSO solutions, at room -temperature and 77 K, with an MiniScope MS200; Magnettech Ltd. (Berlin, Germany) X-band spectrometer (9.3--9.6 GHz), connected to a PC equipped with a 100 kHz field modulation unit. The g factors were quoted relative to the standard marker tetracyanoethylene (g = 2.00277). Magnetic susceptibility measurements were performed at room temperature in the polycrystalline state on a Faraday magnetic balance (home-made). The molar conductance of the complexes in dimethylformamide solutions (10^−3^ M), at room temperature, were measured using a Consort type C-533 conductivity instrument.

### X-ray crystallography

Crystallographic measurements for (**HL**), **2**, **4**, **5** were carried out with an Oxford-Diffraction XCALIBUR E CCD diffractometer equipped with graphite-monochromated Mo K~α~ radiation. The unit cell determination and data integration were carried out using the CrysAlis package of Oxford Diffraction [@b26]. All structures were solved by direct methods using SHELXS-97 [@b27] and refined by full-matrix least-squares on F~o~^2^ with SHELXL-97 [@b27]. All atomic displacements for non-hydrogen, non-disordered atoms were refined using an anisotropic model. All H atoms attached to carbon were introduced in idealized positions using the riding model with their isotropic displacement parameters fixed at 120% of their riding atom. Positional parameters of the H attached to N and O atoms were obtained from difference Fourier syntheses and verified by the geometric parameters of the corresponding hydrogen bonds. The structure of **2** was found to be a non-merohedral twin and it was treated as two-component system using tools of CrysAlis package. The twin data reduction module created a single hklf5 file containing reflections from both lattices, where an overlap decomposition algorithm was employed to resolve the overlapping reflections. This file was used for final structure refinement in conjunction with a BASF parameter that was equal to 0.57431. There were not practically reflections beyond of theta 24.1° because the low quality of the studied crystal, but the theta range (2.83--24.10°) for data refinement was enough to investigate the molecular *architecture of the given complex*. The coordinates of the reference atoms of all studied complexes were deposited with the Cambridge Crystallographic Data Centre.

The geometric parameters were calculated and the figures were drawn with the use of the PLATON program [@b26]. The hydrogen atoms not involved in the hydrogen bonding were omitted from the generation of the packing diagrams. The disordered water molecule was not included in the packing diagram of **4**.

Synthesis of the 1-phenyl-3-methyl-4-benzoyl-5-pyrazolone 4-ethylthiosemicarbazone
----------------------------------------------------------------------------------

Previously, the two keto-enol tautomeric forms of 1-phenyl-3-methyl-4-benzoyl-5-pyrazolone (*Phmbp*) in DMSO were investigated by ^1^H NMR and ^13^C NMR spectroscopy. ^1^H NMR (DMSO- d~6~; δ, ppm): 2.28 (s-CH~3~); 4.00 wide line (OH + H~2~O from DMSO); 7.30--7.70 m (CH -- benzene); ^13^C NMR (DMSO- d~6~; δ, ppm): 14.74 CH~3~; 104.79, 137.47, 157.56 (C -- pyrazole); 121.70, 126.68, 128.50, 129.20, 129.49, 132.28 (CH -- benzene); 139.35, 150.56(C -- benzene); 190.03 C=O. The equilibrium process is shifted to the enolic form of the exocyclic carbonyl from the pyrazole ring. The enolic tautomeric form of *(Phmbp)* predominates in solution and the condensation reaction with thiosemicarbazide is shown in Scheme[1](#sch08){ref-type="fig"}.

![Enolisation mechanism and reaction of condensation in solution.](jcmm0019-0865-f8){#sch08}

A solution of 1-phenyl-3-methyl-4-benzoyl-5-pyrazolone (0.278 g, 1 mmol) in methanol (10 ml) was added to a solution of 4-ethylthiosemicarbazide (0.119 g, 1 mmol) in methanol (20 ml). The mixture was stirred for 2 hrs, at room temperature and refluxed at 70--80°C for 4 hrs. The resulting yellow precipitate was filtered, washed with methanol and recrystallized from methanol-ethanol (1:2, v/v). Fine yellow crystals obtained upon slow evaporation at room temperature were characterized, including the use of single crystal X-ray diffraction. Yield: 77%; M.p. 182--183°C; M.wt.: 379; *Anal*. Calc. for C~20~H~21~N~5~OS: C, 63.32; H, 5.54; N, 18.46. Found: C, 64.02; H, 4.94; N, 18.59%.

IR (KBr, cm^−1^): υ(N^4′^H) 3357, υ(N^2′^H) 3170, υ(C-O) 1230, υ(CH=N^1^) 1612, υ(N^1′^-N^2′^) 1015, υ(C=S+C=N, C=S) 1280, 849.

^1^H NMR (DMSO-d~6~; δ, ppm): 1.17 (t, J = 7.15 Hz, 3H ethyl), 1.79 (s, 3H methyl); 3.64 (q, J = 7.15 Hz, 2H ethyl); 7.30--7.98 (m, 10H benzene), 8.5 (s, 1H, NH-); 10.31 (s, 1H, NH-N=).

^13^C NMR (DMSO-d~6~; δ, ppm): 13.49 CH~3~(ethyl); 14.99 CH~3~-; 39.09 CH~2~ (ethyl); 116.74; 120.96; 124.67; 126.36; 128.26; 128.54; 128.84; 129.29; 129.53; 129.82; 130.90; 137.29; 137.68, 147.55 (benzene and pyrazole); 148.0 C=N; 177.74; C=S.

General procedure for the preparation of the metal complexes
------------------------------------------------------------

Complexes were prepared by a direct reaction between the ligand and the corresponding metal salts.

### Synthesis of the complex \[Cu(L)(Cl)\]·C~2~H~5~OH (**1**)

A hot solution of CuCl~2~·2H~2~O (0.256 g, 1.5 mmol) in ethanol (10 ml) was added to a hot solution of HL (0.568 g, 1.5 mmol) in ethanol (15 ml). The mixture was stirred for 2 hrs at 50--60°C. The brown precipitate formed was separated by filtration, washed with cold ethanol and recrystallized from methanol-ethanol (1:1, v/v). X-ray quality single crystals were obtained.

Yield: 73%; M.wt.: 523.5; *Anal*. Calc. for C~22~H~26~CuClN~5~O~2~S: C, 50.42; H, 4.96; Cu, 12.22; Cl, 6.78; N, 13.37. Found: C, 50.83; H, 4.63; Cu, 12. 02; Cl, 6.54; N, 13.18%.

IR (KBr, cm^−1^): υ(N^4^-H) 3356; υ(N^2^-H) 3171; υ(C-O) 1214; υ(C=N) 1598; υ(C=S+C=N, C=S) 1262, 833. The complex is soluble in DMF and DMSO, and is partially soluble in ethanol and methanol.

### Synthesis of the complex \[Cu(L)~2~\]·H~2~O (**2**)

The ligand HL (0.758 g, 2 mmol) dissolved in hot methanol (15 ml) and 3--4 drops of glacial acetic acid was added to Cu(OAc)~2~·H~2~O (0.200 g, 1 mmol) dissolved in ethanol (15 ml). The mixture was refluxed for 2 hrs at 50--60°C. The resulting solution was left to stand at room temperature and after several days, green-brown X-ray quality single crystals were obtained.

Yield: 75%; M.wt.: 838; *Anal*. Calc. for C~40~H~42~CuN~10~O~3~S~2~: C, 57.27; H, 5.01; Cu, 7.63; N, 16.70. Found: C, 57.45; H, 4.89; Cu, 7.51; N, 16.57%.

IR (KBr, cm^−1^): υ(N^4^-H) 3354; υ(N^2^-H) 3149; υ(C-O) 1230; υ(C=N) 1600; υ(C-S) 601. The complex is soluble in DMF and DMSO, and is partially soluble in ethanol and methanol.

### Synthesis of the complex \[Cu(L)(Br)\]·H~2~O (**3**)

#### Purple solid

Yield 77%; M.wt.: 522; *Anal*. Calc. for C~20~H~20~CuBrN~5~OS: C, 45.97; H, 3.83; Cu, 12.26; Br, 15.32; N, 13.40. Found: C, 46.12; H, 3.68; Cu, 12.08; Br, 15.14; N, 13.22%.

IR (KBr, cm^−1^): υ(N^4^-H) 3354; υ(N^2^-H) 3172; υ(C-O) 1209; υ(C=N) 1597; υ(C=S+C=N, C=S) 1260, 830. The complex is soluble in DMF and DMSO and insoluble in ether.

### Synthesis of the complex \[Cu(L)(NO~3~)\]·2CH~3~CH~2~OH (**4**)

#### Dark solid

Yield: 69%; M.wt.: 504; *Anal*. Calc. for C~20~H~20~CuN~6~O~4~S: C, 47.60; H, 3.96; Cu, 12.69; N, 16.66. Found: C, 47.81; H, 3.69; Cu, 12.48; N, 16.52%.

IR (KBr, cm^−1^): υ(N^4^-H) 3356; υ(N^2^-H) 3170; υ(C-O) 1211; υ(C=N) 1602; υ(C=S+C=N, C=S) 1258, 832. The complex is soluble in DMF, DMSO, partially soluble in ethanol, methanol and insoluble in ether.

### Synthesis of the complex \[VO~2~(L)\]·2H~2~O (**5**)

#### Pale yellow solid

Yield: 71%; M.wt.: 497; *Anal*. Calc for C~20~H~24~VN~5~O~5~S: C, 48.28; H, 4.82; V, 10.26; N, 14.08. Found: C, 48.42; H, 4.67; V, 10.02; N, 13.92%.

IR (KBr, cm^−1^): υ(N^4^-H) 3355; υ(N^2^-H) 3168; υ(C-O) 1213; υ(C=N) 1597; υ(C=S+C=N, C=S) 1261, 831. The complex is soluble in DMF and DMSO, partially soluble in ethanol and insoluble in ether.

### Synthesis of the complex \[Ni(L)~2~\]·H~2~O (**6**)

#### Green solid

Yield: 69%; M.wt.: 888; *Anal*. Calc for C~43~H~47~NiN~11~O~3~S~2~: C, 58.10; H, 5.29; Ni, 6.64; N, 17.34. Found: C, 58.32; H, 5.08; Ni, 6.48; N, 17.14%.

IR (KBr, cm^−1^): υ(N^4^-H) 3357; υ(N^2^-H) 3151; υ(C-O) 1230; υ(C=N) 1603; υ(C-S) 589. The complex is soluble in DMF, DMSO, partially soluble in ethanol, methanol and insoluble in ether.

Results and discussion
======================

Antibacterial and antifungal activity
-------------------------------------

Experimental results obtained from the study of antimicrobial activity (Table[1](#tbl1){ref-type="table"}) demonstrate that the ligand (**HL**) is not active but the copper complexes **1**, **2**, **3**, **4** have bacteriostatic and bactericidal activity in a concentration range of 1.5--30 μg/ml towards both Gram-positive and Gram-negative bacteria. In comparison, the antimicrobial data characteristics for *furacillinum* used in medical practice are given. The antimicrobial activity displayed by the copper complexes **1**, **2**, **3**, **4** is 3--6 times higher towards Staphylococcus aureus and Bacillus cereus than *furacillinum* and exceeds by 22--25 times the bacteriostatic activity towards the majority of Salmonella abony Gram-negative bacteria. The MIC and MBC are influenced by the presence of copper in the composition of coordination compounds.

###### 

Antibacterial and antifungal activities of ligand (HL) and complexes 1--4 as MIC/MBC values (μg/ml)

  Compounds                                *E. coli* (G-)   *S. abony* (G-)   *S. aureus* (G+)   *B. cereus* (G+)   *C. albicans*                                   
  ---------------------------------------- ---------------- ----------------- ------------------ ------------------ --------------- ------- ------- ------- ------- -------
  **HL**                                   \>600            \>600             \>600              \>600              \>600           \>600   \>600   \>600   \>600   \>600
  \[Cu(L)(Cl)\] C~2~H~5~OH (**1)**         \>600            \>600             3.0                7.0                15              30      3.0     15      1.5     3.0
  \[Cu(L)~2~\]·H~2~O (**2**)               \>600            \>600             1.5                7.0                7.0             1.5     1.5     3       1.5     1.5
  \[Cu(L)(Br)\] H~2~O (**3**)              \>600            \>600             3.0                7.0                3.0             70      1.5     3       1.5     1.5
  \[Cu(L)(NO~3~)\]·2CH~3~CH~2~OH (**4**)   \>600            \>600             4.0                6.0                4.0             6.0     1.2     1.2     1.4     4.0
  CuCl~2~·2H~2~O                           \>600            \>600             \>600              \>600              \>600           \>600   \>600   \>600   \>600   \>600
  CuBr~2~                                  \>600            \>600             \>600              \>600              \>600           \>600   \>600   \>600   \>600   \>600
  Cu(NO~3~)~2~·3H~2~O                      \>600            \>600             \>600              \>600              \>600           \>600   \>600   \>600   \>600   \>600
  Furacillinum                             18.5             37.5              75                 150                9.35            9.35    9.35    18.5    --      --
  Nystatine                                --               --                --                 --                 --              --      --      --      80      80

*E. coli* (*Escherichia coli,* ATCC 25922); *S. abony* (*Salmonella abony,* NCTC 03/03); *S. aureus* (*Staphylococcus aureus*, ATCC 25923); *B. cereus* (*Bacillus cereus*, NCTC 8035); *C. albicans* (*Candida albicans*); MIC, minimum inhibitory concentration; MBC, minimum bactericide concentration.

The data concerning the study of antimycotic properties of the copper complexes **1**, **2**, **3**, **4** show that they also display bacteriostatic and bactericidal activity in a concentration range of 1.5--4.0 μg/ml towards Candida fungi. For comparison, we also added data regarding the activity of nystatine, a compound used in medicine for mycoses treatment. The results show that the copper complexes have antimycotic activity against Candida fungi, 20--25 times higher than that of nystatine.

The antibacterial results evidently show that the activity of the Schiff base compounds became more pronounced when coordinated to the metal ions. This is probably due to the greater lipophilic nature of the complexes. Such increased activity of the metal chelates can be explained on the basis of chelating theory [@b28]. Upon chelation, the polarity of the metal ion is reduced to a greater extent as a result of the overlap of the ligand orbital and partial sharing of the positive charge of the metal ion with donor groups. Further, it increases the delocalization of π-electrons over the whole chelate ring and enhances the lipophilicity of the complex. This increased lipophilicity enhances the penetration of the complexes into lipid membrane and blocks the metal binding sites on enzymes of micro-organisms.

Antileukaemia activity
----------------------

The ligand (1-phenyl-3-methyl-4-benzoyl-5-pyrazolone 4-ethyl-thiosemicarbazone) and its metal complexes (Table[2](#tbl2){ref-type="table"}) were tested as inhibitors of HL-60 cell proliferation using three concentrations: 0.1, 1.0 and 10 μmol/L. At all concentrations the ligand did not have inhibitory activity. Therefore, the presence of the metal ion in the Schiff bases composition is important. This fact is confirmed specially for copper complexes. The copper complexes, including the tridentate ONS ligand, demonstrate an important antiproliferative activity for HL-60 leukaemia cells compared to those containing inner sphere halogen.

###### 

Antiproliferative activity of ligand and metal complexes on human leukaemia HL-60 cells at three concentrations

  Compound                                 Inhibition of cell proliferation (%)[\*](#tf2-1){ref-type="table-fn"}          
  ---------------------------------------- ----------------------------------------------------------------------- ------ -----
  **HL**                                   0                                                                       0      0
  \[Cu(L)(Cl)\]·C~2~H~5~OH (**1)**         98.9                                                                    41.3   2.0
  \[Cu(L)~2~\]·H~2~O (**2**)               99.9                                                                    96.0   5.0
  \[Cu(L)(Br)\]·H~2~O (**3**)              98.8                                                                    35.5   0
  \[Cu(L)(NO~3~)\]·2CH~3~CH~2~OH (**4**)   96.8                                                                    45.8   4.0
  \[VO~2~ (L)\]·2H~2~O (**5**)             4.0                                                                     0      0
  \[Ni(L)~2~\]·H~2~O (**6**)               5.7                                                                     0      0
  CuCl~2~·2H~2~O                           0                                                                       0      0
  (VO)SO~4~·2H~2~O                         0                                                                       0      0
  NiCl~2~·6H~2~O                           0                                                                       0      0

SEM \< ±4% of a single experiment in triplicate.

If copper is capsulated with two ligands (complex **2**), the antiproliferative activity is the highest and the concentration dependence changes from 5.0% to 99.9%. The antiproliferative activity of the copper complexes is of the same significance as for doxorubicin, which is utilized in medicinal practice as antileukemia drug.

Finally, the nature of metal ion in the coordination compound is very important and the antiproliferative activity dramatically decreases for vanadium and nickel.

The physico-chemical analyses confirmed the composition and the structure of the newly obtained complex combinations. Depending on the metal salt anion used, the ligand acts as a mononegative tridentate (**1**, **3**, **4**, **5**) through the thioenolic sulphur, the azomethine nitrogen and exocyclic carbonyl oxygen of the pyrazol moiety or a mononegative bidentate through the thioenolic sulphur and the azomethine nitrogen (**2**, **6**). The sensitivity spectrum of the microbial strains towards the ligand and the corresponding complexes was determined by qualitative and quantitative methods.

The antimicrobial data given for the compounds presented in this article showed that the metal complexes generally have better activity than the free ligand. The antimicrobial activity was dependent on the microbial species tested and metal salt anion used.

The antiproliferative activity towards HL-60 cells of some complex combinations occurred in a concentration-dependent manner in the range of 1--10 μM, while a similar effect, was not exhibited by the ligands alone or the copper salts used for the metal complex synthesis at identical tested concentrations. The complex **2**, which is capsulated with two ligands, demonstrates the highest antiproliferative activity of the series of compounds.

Chemistry
---------

New metal compounds **1**--**6** were synthesized in methanol with good yield. They are microcrystalline solids that, decomposed above 250°C, are soluble in organic solvents such as DMF, DMSO, chloroform, but insoluble in ether. The molar conductance values of the soluble complexes in DMF (8--15 ohm^−1^ cm^2^/mol) showed that complexes **1**--**6** are non-electrolytes [@b29]. The elemental analyses data of the thiosemicarbazone and its complexes (see Experimental) were compatible with the structures of the ligand and of the complexes.

The green and brown colours are common to complexes involving thiosemicarbazone coordination because of the sulphur-to-metal charge-transfer bands, which dominate their visible spectra [@b30].

Structural characterization of the ligand (HL) and the complexes (2, 4 and 5)
-----------------------------------------------------------------------------

Crystals of (**HL**), \[Cu(L)~2~\]·H~2~O (**2**), \[Cu(L)(NO~3~)\]·2CH~3~CH~2~OH (**4**), \[VO~2~(L)\]·2H~2~O (**5**), suitable for single crystal X-ray study were grown from acetonitrile, by slow evaporation. The principal crystallographic data and the refinement details are summarized in Table[3](#tbl3){ref-type="table"}. Selected bond lengths and angles are presented in Table[4](#tbl4){ref-type="table"}. The single crystal X-ray study revealed that all the compounds have a molecular structure built from the neutral entities depicted in Figures[1](#fig01){ref-type="fig"}--[4](#fig04){ref-type="fig"}.

###### 

Crystallographic data, details of data collection and structure refinement parameters for compound (HL), 2, 4 and 5

  Compound                                        HL                 2                            4                       5
  ----------------------------------------------- ------------------ ---------------------------- ----------------------- ----------------------
  Chemical formula                                C~20~H~21~N~5~OS   C~40~H~42~ CuN~10~O~3~S~2~   C~20~H~20~CuN~6~O~4~S   C~20~H~24~VN~5~O~5~S
  M (g/mol)                                       379.47             838.5                        508.02                  497.44
  Temperature (K)                                 293                293                          293                     293
  Wavelength (Å)                                  0.71073            0.71073                      0.71073                 0.71073
  Crystal system                                  Orthorhombic       Triclinic                    Monoclinic              Monoclinic
  Space group                                     *Pbcn*             *P-1*                        *P2*~*1*~*/c*           *P2*~*1*~*/n*
  a (Å)                                           14.5376(6)         11.374(2)                    13.534(5)               10.9731(6)
  b (Å)                                           12.7713(4)         12.375(2)                    23.495(2)               10.6930(7)
  c (Å)                                           21.1856(7)         14.829(2)                    7.5128(5)               19.0149(13)
  α (^0^)                                         90                 99.935(14)                   90                      90
  β (^0^)                                         90                 98.607(13)                   96.163(10)              91.424(6)
  γ (^0^)                                         90                 97.504(15)                   90                      90
  V (Å^3^)                                        3933.4(3)          2006.3(6)                    2375.2(5)               2230.4(2)
  D~calc~ (g/cm^3^)                               1.282              1.388                        1.421                   1.481
  μ (mm^−1^)                                      0.184              0.700                        1.046                   0.581
  F(0 0 0)                                        1600               874                          1044                    1032
  Goodness-of-fit on F^2^                         0.982              0.600                        1.047                   0.971
  Final R~1~, wR~2~ \[I \> 2σ(I)\]                0.0497             0.0575                       0.0691                  0.0683
  0.1045                                          0.0597             0.1783                       0.0937                  
  R~1~, wR~2~ (all data)                          0.0891             0.2785                       0.1142                  0.1420
  0.1178                                          0.0927             0.2003                       0.1130                  
  Largest difference in peak and hole (e Å^−3^)   0.256, −0.222      0.257, −0.263                0.744, −0.362           0.509, −0.348

###### 

Selected bond lengths and angles for (HL), 2, 4 and 5

  Bond angels                                   ω, deg.                                         
  --------------------------------------------- ------------- -------------------- ------------ ------------
  Cu(1) \[V(1)\]-S(1)                                         2.246(2)             2.2471(16)   2.3647(15)
  Cu(1) \[V(1)\]-S(1A) \[O(1)\]                               2.258(3)             1.916(4)     1.904(3)
  Cu(1) \[V(1)\]-N(1)                                         1.987(5)             1.965(4)     2.244(3)
  Cu(1) \[V(1)\]-N(1A) \[O(2)\]                               1.973(6)             2.001(5)     1.638(3)
  S(1)-C(1) (S(1A)-C(1A))                       1.695(2)      1.693(8) (1.706(8)   1.697(6)     1.696(4)
  N(1)-N(2)                                     1.374(2)      1.376(7)             1.363(6)     1.390(4)
  N(1)-C(2)                                     1.293(3)      1.307(7)             1.325(6)     1.313(5)
  N(2)-C(1)                                     1.359(3)      1.340(7)             1.349(7)     1.341(5)
  N(3)-C(1)                                     1.313(3)      1.336(9)             1.309(7)     1.314(5)
  N(3)-C(11)                                    1.453(3)      1.445(8)             1.496(8)     1.458(5)
  C(3)-C(2)                                     1.470(3)      1.448(9)             1.409(7)     1.418(5)
  C(3)-C(4)                                     1.434(3)      1.436(11)            1.402(7)     1.399(5)
  C(4)-N(5)                                     1.384(3)      1.396(9)             1.330(7)     1.360(5)
  O(1)-C(4)                                     1.250(3)      1.244(8)             1.279(6)     1.300(4)
  N(5)-N(4)                                     1.384(3)      1.370(8)             1.404(6)     1.384(4)
  C(13)-N(4)                                    1.331(3)      1.309(10)            1.298(6)     1.326(5)
  N(5)-C(15)                                    1.420(3)      1.413(10)            1.432(6)     1.419(5)
  C(13)-C(14)                                   1.494(3)      1.519(10)            1.490(7)     1.496(5)
  **Bond angles**                               **ω, deg.**                                     
  N(1A) \[O(2)\]-Cu(1) \[V(1)\]-N(1)                          105.3(2)             175.1(2)     153.26(15)
  N(1A) \[O(2)\]-Cu(1) \[V(1)\]-S(1)                          148.0(2)             89.17(15)    86.58(12)
  N(1)-Cu(1) \[V(1)\]-S(1)                                    85.42(19)            87.22(13)    78.23(9)
  N(1A) \[O(2)\]-Cu(1) \[V(1)\]-S(1A)\[O(1)\]                 86.2(2)              89.28(18)    95.64(14)
  N(1)-Cu(1) \[V(1)\]-S(1A) \[O(1)\]                          147.5(2)             94.39(16)    83.26(12)
  S(1)-Cu(1) \[V(1)\]-S(1A) \[O(1)\]                          100.88(9)            178.14(11)   141.32(10)
  C(1)-S(1)-Cu(1) \[V(1)\]                                    95.1(3)              96.5(2)      102.61(17)
  N(3)-C(1)-S(1)                                124.58(18)    122.8(6)             122.9(4)     123.1(3)
  N(2)-C(1)-S(1)                                117.91(17)    121.4(6)             119.6(4)     119.9(3)
  N(3)-C(1)-N(2)                                117.4(2)      115.5(7)             117.4(5)     117.0(4)
  N(1)-C(2)-C(3)                                127.5(2)      127.8(8)             120.1(5)     118.5(4)
  O(1)-C(4)-N(5)                                123.3(2)      125.4(9)             121.9(5)     123.4(4)
  O(1)-C(4)-C(3)                                130.7(2)      132.1(8)             130.8(5)     128.4(4)
  N(4)-N(5)-C(4)                                108.51(19)    113.6(8)             111.7(4)     110.4(3)
  N(4)-C(13)-C(3)                               109.9(2)      112.5(9)             111.4(4)     111.7(4)
  N(4)-C(13)-C(14)                              118.0(2)      117.2(8)             118.1(5)     118.0(4)

![ORTEP drawing for compounds HL, 2, 4, 5 with the atomic labelling. Thermal ellipsoids are shown with the 50% probability level.](jcmm0019-0865-f1){#fig01}

![(A) Crystal packing of HL representing the *2-D* layers parallel to (*001*) plane. (B) Fragment of molecular packing in the crystal of HL.](jcmm0019-0865-f2){#fig02}

![(A)The crystal packing of 2 showing the formation of chains which are aligned along \[0 1 0\] direction because of water molecules. (B) The crystal packing showing the *3D* hydrogen-bonded network built from complexes of 5.](jcmm0019-0865-f3){#fig03}

![(A) The dimer formation where the complexes are linked by NO~3~-groups. (B) The crystal packing of 4 representing the consolidation of dimers into chains aligned along \[1 0 0\] direction.](jcmm0019-0865-f4){#fig04}

In (**HL**), the substituents at the N(2)--C(1) bonds are in the *E* positions. The S(1)-N(1)-N(2)-N(3)-C(1)-C(2) core of the ligand essentially planar to within 0.075 Å but the molecule is non-planar. The best planes of the phenol (C(5)--C(10)), (*C*(3)C(4)C(13)N(4)N(5)) and (C(15)-C(20)) rings are inclined to this core at angles of 42.2°, 34.7° and 14.6°, respectively.

In complex **2** the central ion is a tetrahedral coordination environment provided by two monodeprotonated bidentate ligands, which exhibit typical (N~2~S~2~) co-ordinating behaviour for thiosemicarbazone moieties [@b31],[@b32] resulting into the formation of the five-membered chelate ring. The distances between the centres of S(1) and C(1) atoms, for complexes **2**, **4** and **5** are 1.693(8), 1.697(6), 1.696(4) Å, respectively, which is close to the C-S single bond and from which we can deduce that the structures of the complexes have a thiol form.

In complex **4**, the copper atom is tetracoordinated with a square planar geometry while in complex **5**, the coordination polyhedron of the central ion can be described as a distorted square pyramid. In these complexes, the thiosemicarbazone ligand coordinates to the metal atom in a tridentate manner using its azomethine nitrogen, thiolate sulphur and the exocyclic carbonyl oxygen of the pyrazol moiety, resulting a five-membered chelate ring and the other six membered. The basal plane of the square pyramid of the metal atom in **5** is formed by the S1, O1, O2 and N1 atoms of the monodeprotonated (**HL**) ligands. The apexes of the metals\' coordination pyramids in **5** are occupied by oxygen atoms O3 with distances of 1.605(1) Å. In complexes **4** and **5,** the distance between the centres of O(1) and C(4) atoms is 1.279(6) and 1.300(4) Å, respectively, which is similar to the value for a C=O double bond. In the crystal structure of **4**, the complexes form dimers which are linked by NO~3~^−^ groups. The dimers are joined into chains through the hydrogen bonds N2-H...O4 (1 − *x*,−*y*,1 − *z*) while in the crystal structure of **5,** the complexes are linked together by H-bonds to form a three dimensional framework. Table[5](#tbl5){ref-type="table"} shows the H-bonding interactions of (**HL**) and complexes **2**, **4** and **5**.

###### 

Hydrogen bonds in X-ray structures for (HL), 2, 4 and 5

  D-H...A         d(D...H), Å   d(H...A), Å   d(D...A), Å   ∠(DHA), deg.   Symmetry transformation for H-acceptor
  --------------- ------------- ------------- ------------- -------------- ----------------------------------------
  (**HL**)                                                                 
   N4-H...S1      0.86          2.38          3.2261        171            1 − *x*,1 − *y*,−*z*
   N2-H...O1      0.86          2.02          2.7315        139            *x*,*y*,*z*
   N3-H...N1      0.86          2.24          2.6225        107            *x*,*y*,*z*
   N3-H...O1      0.86          2.34          3.0114        135            1/2 − *x*,−1/2 + *y*,*z*
   C11-H...S1     0.97          2.79          3.1035        1100           *x*,*y*,*z*
   C16-H...O1     0.93          2.46          2.9569        114            *x*,*y*,*z*
   C18-H...N1     0.93          2.59          3.4532        154            1/2 + *x*,3/2 − *y*,−*z*
  **2**                                                                    
   N2-H...O1      0.86          1.75          2.575(7)      160            *x*,*y*,*z*
   N2A-H...O1A    0.86          1.74          2.560(8)      159            *x*,*y*,*z*
   N3-H...O2      0.86          2.08          2.922(10)     167            *x*,−1 + *y*,*z*
   O2-H...O1      0.83(6)       1.95          2.760(9)      164            *x*,1 + *y*,*z*
   N3A-H...O2     0.86          2.19          3.047(10)     175            *x*,*y*,*z*
   O2-H...O1A     0.83(8)       1.95(8)       2.705(9)      151(9)         *x*,*y*,*z*
   C16-H...N4     0.93          2.44          2.769(12)     101            *x*,*y*,*z*
   C20A-H...O1A   0.93          2.40          2.934(11)     117            *x*,*y*,*z*
   C11A-H...S1A   0.97          2.72          3.121(10)     106            *x*,*y*,*z*
   C20-H...O1     0.93          2.31          2.923(10)     123            *x*,*y*,*z*
   C11-H...S1     0.97          2.66          3.097(10)     108            *x*,*y*,*z*
  **4**                                                                    
   N2-H...O4      0.86          2.32          3.0173        139            1 − *x*,−*y*,1 − *z*
   C16-H...O1     0.93          2.44          2.9235        113            *x*,*y*,*z*
   C17-H...O3     0.93          2.51          3.2717        139            −*x*,−*y*,−*z*
  **5**                                                                    
   N3-H...O2W     0.86          2.00          2.7948        153            1 − *x*,1 − *y*,−*z*
   O2W-H...O3     0.85          1.98          2.8033        164            −1 + *x*,*y*,*z*
   O2W-H...O1W    0.85          1.91          2.7588        172            1/2 − *x*,1/2 + *y*,1/2 − *z*
   N2-H...O2W     0.86          2.06          2.8274        148            1 − *x*,1 − *y*,−*z*
   O1W-H...O2     0.85          1.89          2.7355        172            −1 + *x*,*y*,*z*
   O1W-H...N4     0.85          2.22          3.0383        161            *x*,*y*,*z*
   C20-H...N4     0.93          2.44          2.7778        102            *x*,*y*,*z*
   C11-H...S1     0.97          2.74          3.0678        101            *x*,*y*,*z*
   C16-H...O1     0.93          2.21          2.8616        126            *x*,*y*,*z*

Infrared spectra and coordination mode
--------------------------------------

The tentative assignments of the significant IR spectral bands of (**HL**) and its complexes are reported in the Experimental section. The IR spectra of the complexes are compared with those for the free ligand to determine the changes that might occur during complex formation. The proposed assignments are based on previous results [@b19]--[@b21],[@b33],[@b34] and pertinent references [@b35]--[@b41].

The υ(C=N) band of the thiosemicarbazone at 1612 cm^−1^ shifted to lower frequencies (1597--1603 cm^−1^) in the complexes indicating coordination *via* the azomethine nitrogen. The υ(N-N) strong band of the thiosemicarbazone is found at 1015 cm^−1^. The increase in the frequency of this band in the spectra of the complexes is due to the increase in the double bond character (the bond strength). This is a confirmation of the coordination of the ligand through the azomethine nitrogen atom [@b42].

In the free ligand spectrum, the two bands appearing at the frequencies at 1280 and 849 cm^−1^ have been assigned to υ(C=S+C=N) and υ(C=S). Evidence of the coordination of the thionic sulphur is further supported by the shifting of these bands in the spectra of the complexes **1**, **3**, **4** and **5**, to a lower wave number [@b43]--[@b46]. The shift of the υ(N^2^-H) band in the spectra of the complexes **2** and **6** indicates the deprotonation of the hydrazinic proton which is in accordance with the coordination of the sulphur atom in the thiolate form [@b44]--[@b46].

The band from 1230 cm^−1^ because of υ(C-O), for the exocyclic enolic group in the free ligand spectrum is shifted by 18--22 cm^−1^ to lower energies in the spectra of the complexes **1**, **3**, **4** and **5**. This indicates that the exocyclic enolic oxygen is bonded to the metallic ions [@b35],[@b36],[@b47],[@b48]. In the IR spectra for complexes **2** and **6**, υ(C-O) remains un-modified, indicating that the exocyclic ketonic oxygen of the antipyrine ring is not involved in the coordination [@b49].

Electronic spectra and magnetic studies
---------------------------------------

The tentative assignments of the significant electronic spectral bands of ligand and their complexes are presented in Table[6](#tbl6){ref-type="table"}. The electronic spectrum in the polycrystalline state of ligand (**HL**) showed the intraligand absorption maxima: 38,400 and 28,900 cm^−1^, assigned to π→π\* and n→π\* transitions, corresponding to azomethine and thioamide groups of the ligand [@b50]. In the spectra of the complexes, these bands are shifted to lower energies and new bands appeared in the regions 37,000--36,300 cm^−1^ and 27,700--26,300 cm^−1^.

###### 

Electronic spectra (cm^−1^) and magnetic moment (BM) of the complexes 1--6

  Metal complex molecular formula          Transitions d-d (cm^−1^)    μ~eff~ (BM)                       Geometry                                 
  ---------------------------------------- --------------------------- --------------------------------- -------------------------- ------------- --------------------
  \[Cu(L)(Cl)\]·C~2~H~5~OH (**1**)         ^2^B~1g~→^2^B~2g~ 11,200    ^2^B~1g~→^2^E~g~ 15,870           ^2^B~1g~→^2^A~1g~ --       1.54          Square-planar
  \[Cu(L)~2~\]·H~2~O (**2**)               ^2^B~2~→^2^E 10,500         ^2^B~2~→^2^B~1~(^2^A~1~) 14,390   --                         1.75          Pseudo-tetrahedral
  \[Cu(L)(Br)\]·H~2~O (**3**)              ^2^B~1g~→^2^B~2g~ 12,050    ^2^B~1g~→^2^E~g~ 16,260           ^2^B~1g~→^2^A~1g~ 19,250   1.69          Square-planar
  \[Cu(L)(NO~3~)\]·2CH~3~CH~2~OH (**4**)   ^2^B~1g~→^2^B~2g~ 11,900    ^2^B~1g~→^2^B~2g~ 15,620          ^2^B~1g~→^2^E~g~ --        1.82          Square-planar
  \[VO~2~(L)\]·2H~2~O (**5**)                                                                            25,680(CT)                 Diamagnetic   Square-pyramidal
  \[Ni(L)~2~\]·H~2~O (**6**)               ^3^A~2~→^3^T~1~(F) 10,750   ^3^A~2~→^3^T~1~(P) 16,950         --                         3.56          Square-planar

The spectra of the complexes **1**, **3** and **4** exhibit d--d bands corresponding to the transitions specific to the square-planar complexes with (^2^B~1g~) ground state [@b51]. The room temperature magnetic moment values (1.50, 1.62 and 1.82 B.M) of the solid copper (II) complexes **1**, **3** and **4**, respectively, are indicative of anti-ferromagnetic interaction through molecular association for square-planar geometry [@b52].

In the electronic spectrum of complex **2,** a broad band was observed at 14,390 cm^−1^ due to a d~*xy*~ (^2^B~2~)→ (^2^A~1~), (^2^B~1~) transition, suggesting a pseudo-tetrahedral configuration around the central metal ion [@b51],[@b53]. A second transition appeared as a weak shoulder on the broad band. The magnetic moment of complex (1.75 B.M) is normal for copper (II) with pseudo-tetrahedral stereochemistry [@b52],[@b54].

The electronic spectrum of complex **5** shows an intense and broad band, specific for complexes with metallic ion d^0^ [@b55].

For complex **6**, the electronic spectrum showed a two band association for tetrahedral geometry [@b51]. The magnetic moment value (3.56 B.M) corresponding to two unpaired electrons per nickel (II) centres for square-planar configuration [@b52],[@b54].

EPR spectra
-----------

The EPR spectral parameters of the copper(II) complexes 1--4 in the polycrystalline state at 298 K and in DMSO solution at 77 K are presented in Table[7](#tbl7){ref-type="table"}. The EPR spectra of the complexes recorded in the polycrystalline and solution state provide information about the coordination environment around copper(II).

###### 

EPR spectral parameters of the copper(II) complexes 1--4

                            1        2        3        4
  ------------------------- -------- -------- -------- --------
  Polycrystalline (298 K)                              
   g~//~                    2.22     2.265    2.21     2.18
   g~⊥~                     2.042    2.053    2.037    2.047
  DMSO (77 K)                                          
   g~//~                    2.219    2.188    2.243    2.241
   g~⊥~                     2.051    2.077    2.062    2.062
   A~//~                    177      174      173      175
   α^2^                     0.7691   0.7410   0.7867   0.7903
   β^2^                     0.9366   0.8570   0.9752   0.9491
   δ^2^                     0.7460   0.9286   0.8376   0.8286
   K~//~                    0.7204   0.6351   0.7672   0.7501
   K~⊥~                     0.5738   0.6881   0.6590   0.6549

The spectra of the compounds 1--4 in the polycrystalline state show only one broad signal, and typical axial behaviour with slightly different g~//~ and g~⊥~ values (Fig.[5](#fig05){ref-type="fig"}). In these complexes, tensor values of g~//~ \> g~⊥~ \> 2.0023 are consistent with a ground state [@b56].

![EPR spectra of 1-4 in the polycristalline state at the room temperature.](jcmm0019-0865-f5){#fig05}

The solution spectra of the complexes were recorded in DMSO at 298 K. The spectra of the complexes **1**, **3** and **4** show three nitrogen superhyperfine lines and five for complex **2**, in the high field component (Fig.[6](#fig06){ref-type="fig"}). The g~//~/A~//~ratio can be used as a empirical convenient of distortion from square-planar structure [@b57],[@b58]. The values of the g~//~/A~//~ratio for complexes **1**, **3** and **4** indicate nearly square-planar environments with small distortions, which is in good agreement with the X-ray determined structure for complex **4**.

![EPR spectra of 1-4 in DMSO solution at the room temperature (second derivative).](jcmm0019-0865-f6){#fig06}

The spectra of all the complexes in frozen DMSO at 77 K are axial with four copper hyperfine lines in the parallel region (Fig.[7](#fig07){ref-type="fig"}). Additionally, in all these complexes, g~//~ \> g~⊥~ \> 2.0023 corresponding to the presence of an unpaired electron in the orbital [@b56]. The energies of d--d transition and the EPR spectral parameters g~//~, g~⊥~ and A~//~, were used to evaluate the bonding parameters α^2^, β^2^, δ^2^. These parameters may be regarded as measures of the covalency of the in-plane σ bonds, in-plane p bonds and out-of-plane π bonds [@b40],[@b59].

![EPR spectra of 1-4 in DMSO solution at 77 K.](jcmm0019-0865-f7){#fig07}

The orbital reduction factors K~//~ and K~⊥~ were calculated using expressions reported elsewhere [@b40],[@b60],[@b61]. The K~//~ and K~⊥~ values, in complexes **1**, **3** and **4**, are in agreement with the relation K~//~ \> K~⊥~. The values of these factors indicate the presence out-of-plane π bonding. For complex **2**, these values indicate the presence of in-plane π bonding (K~//~ \< K~⊥~).
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